According to GenSight Biologics's latest financial reports the company's current earnings (TTM) are -C$39.32 M. In 2023 the company made an earning of -C$39.32 M an increase over its 2022 earnings that were of -C$40.19 M.The earnings displayed on this page is the company's Pretax Income.